Financial Advocates Investment Management Neuro Pace Inc Transaction History
Financial Advocates Investment Management
- $1.71 Billion
- Q4 2024
A detailed history of Financial Advocates Investment Management transactions in Neuro Pace Inc stock. As of the latest transaction made, Financial Advocates Investment Management holds 23,000 shares of NPCE stock, worth $312,340. This represents 0.02% of its overall portfolio holdings.
Number of Shares
23,000
Previous 18,000
27.78%
Holding current value
$312,340
Previous $125,000
105.6%
% of portfolio
0.02%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding NPCE
# of Institutions
54Shares Held
21MCall Options Held
1.3KPut Options Held
100-
Kck Ltd. Tortola, D85.27MShares$71.6 Million78.74% of portfolio
-
Orbimed Advisors LLC San Diego, CA3.41MShares$46.3 Million0.56% of portfolio
-
Morgan Stanley New York, NY2.49MShares$33.9 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT2.43MShares$33 Million1.44% of portfolio
-
Kent Lake Pr LLC Anasco, PR1.25MShares$17 Million3.46% of portfolio
About NeuroPace Inc
- Ticker NPCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,846,900
- Market Cap $337M
- Description
- NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...